Clin Mol Hepatol.  2013 Jun;19(2):179-184. 10.3350/cmh.2013.19.2.179.

A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease

Affiliations
  • 1Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea. hjlee@med.yu.ac.kr

Abstract

Variceal bleeding and hepatorenal syndrome (HRS) are serious and life-threatening complications of advanced liver disease. Terlipressin is widely used to manage both acute variceal bleeding and HRS due to its potency and long duration of action. The most severe (though rare) adverse event is ischemia. The present report describes the case of a patient with gangrene and osteomyelitis secondary to terlipressin therapy. A 71-year-old male with alcoholic liver cirrhosis (Child-Pugh B) and chronic hepatitis C was admitted due to a drowsy mental status. The patient had several experiences of orthopedic surgery. His creatinine level had gradually elevated to 4.02 mg/dL, and his urine output decreased to 500 mL/24 hr. The patient was diagnosed as having grade III hepatic encephalopathy (HE) and type II HRS. Terlipressin and albumin were administered intravenously to treat the HRS over 11 days. Although he recovered from the HE and HRS, the patient developed peripheral gangrene and osteomyelitis in both feet. His right toes were cured with the aid of rescue therapy, but his left three toes had to be amputated. Peripheral gangrene and osteomyelitis secondary to terlipressin therapy occur only rarely, and there is no specific rescue therapy for these conditions. Thus, attention should be paid to the possibility of ischemia of the skin and bone during or after terlipressin therapy.

Keyword

Liver cirrhosis; Hepatorenal syndrome; Terlipressin; Gangrene; Osteomyelitis

MeSH Terms

Aged
Creatinine/blood
Foot/pathology
Gangrene/*etiology
Hepatitis C, Chronic/complications
Humans
Liver Cirrhosis/complications/diagnosis
Liver Diseases/*diagnosis/drug therapy
Lypressin/adverse effects/*analogs & derivatives/therapeutic use
Male
Osteomyelitis/*etiology
Severity of Illness Index
Toe Phalanges/radiography
Vasoconstrictor Agents/*adverse effects/therapeutic use
Vasoconstrictor Agents
Lypressin
Creatinine
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr